Novocure (NVCR) Misses Q4 EPS by 4c, Revenues Miss

Go back to Novocure (NVCR) Misses Q4 EPS by 4c, Revenues Miss

NovoCure Ltd. (NVCR) PT Raised to $59 at Wedbush

March 1, 2019 11:24 AM EST

Wedbush analyst David Nierengarten raised the price target on NovoCure Ltd. (NASDAQ: NVCR) to $59.00 (from $55.00) while maintaining a Outperform rating.

... More